Search for stocks /

Gem Aromatics Q3FY26 Concall Decoded: ₹250 crore capex, 3x capacity jump, and still 9% EBITDA — bold or brave?

1. Opening Hook

After a year of tariff tantrums, GST gymnastics, and mint prices playing hide-and-seek, Gem Aromatics decided this was the perfect time to commission a ₹270 crore greenfield plant. Because why not build a 3x capacity monster when margins are just crawling back to 9%?

Q3 FY26 was supposed to be about “normalization.” Instead, it felt like a transition season — depreciation hit, Dahej ran for just 20 days, and yet management is already talking ₹1,100 crore revenue by FY28.

Cooling agents are online. Phenol derivatives are loading. US tariffs are still annoying. But the real story is Dahej — or as they call it, Krystal — which is expected to do ₹750–800 crore at peak.

If that sounds ambitious, good. Because it gets more interesting from here.


2. At a Glance

  • Standalone Revenue ₹83.9 crore – Growth took a tea break; tariffs joined the party.
  • Standalone EBITDA Margin 9.1% – Mint prices recovered, finally remembered their job.
  • Consolidated Gross Margin 23% (vs 14% QoQ) – Realizations improved; spreadsheets exhaled.
  • Net Loss ₹5 crore (Consol) – Depreciation from ₹250 crore capex said hello.
  • Dahej Capex ₹250 crore deployed – 3x capacity built before demand RSVP’d.
  • FY28 Revenue Target ₹1,050–1,100 crore – Optimism served neat, no dilution.

3. Management’s Key Commentary

“Gross margins improved during the quarter and are trending towards normalized levels.”
(Translation: Mint stopped misbehaving, and customers finally started ordering again 😏)

“We commissioned the cooling agents vertical with WS23 and WS03 on 11 December 2025.”
(Translation: The plant worked for 20 days, but we’re counting the milestone anyway.)

“Total capex at Dahej is approximately ₹270 crores.”
(Translation: We went all-in. Now utilization better show up.)

“We expect 50–60% utilization by next year-end.”
(Translation: Please watch this ramp-up very closely.)

“Krystal should reach ₹750–800 crores revenue in 2–3 years.”
(Translation: Asset turn of 3x — spreadsheets feeling ambitious again.)

“Cooling agents and eugenol are exempt from US tariffs.”
(Translation: We learned from the tariff trauma.)

“We are targeting ₹1,050–1,100 crores revenue with 16–18% EBITDA margin by FY28.”
(Translation: Double revenue, double margins — no pressure at all 😌)

The tone? Confident. The execution bar? Very high.


4. Numbers Decoded

Source table
MetricQ3 FY26 (Standalone)9M FY26 (Standalone)Commentary
Revenue₹83.9 cr₹258.7 crTariffs + GST confusion muted growth
Gross Margin18.4%18.7%Trending upward with mint recovery
EBITDA Margin9.1%9.4%Still far from 16–18% dream
PAT Margin5%5.7%Thin but positive
Depreciation (Consol)₹8.7 crDahej capex impact visible
Dahej Capex Incurred₹250 cr
Join 10,000+ investors who read this every week.
Become a member
error: Content is protected !!